Home › Entities › clinical_trial › Trabectedin First Line Therapy In Unfit Sarcoma Study

Trabectedin First Line Therapy In Unfit Sarcoma Study

clinical trial
MedicalStudy clinical_trial Q64223004
Press Enter · cited answer in seconds

Summary

Trabectedin First Line Therapy In Unfit Sarcoma Study is a clinical trial[1].

Key Facts

  • Trabectedin First Line Therapy In Unfit Sarcoma Study is in the country of Italy[2].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's instance of is recorded as clinical trial[3].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's start time is recorded as +2014-02-28T00:00:00Z[4].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's end time is recorded as +2016-12-31T00:00:00Z[5].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's sponsor is recorded as Italian Sarcoma Group[6].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's main subject is recorded as soft tissue neoplasm[7].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's main subject is recorded as sarcoma[8].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's number of participants is recorded as {'unit': '1', 'amount': '+24'}[9].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's title is recorded as SAFETY AND ACTIVITY OF TRABECTEDIN AS FIRST LINE IN ADVANCED SOFT TISSUE SARCOMA (STS) PATIENTS UNFIT TO RECEIVE STANDARD CHEMOTHERAPY: A PROSPECTIVE PHASE II STUDY WITH CLINICAL AND MOLECULAR CORRELATES[10].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's short name is recorded as TR1US[11].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[12].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's ClinicalTrials.gov ID is recorded as NCT02066675[13].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}[14].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's clinical trial phase is recorded as phase II clinical trial[15].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's research site is recorded as Istituto Oncologico Veneto[16].
  • Trabectedin First Line Therapy In Unfit Sarcoma Study's study type is recorded as interventional study[17].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Trabectedin First Line Therapy In Unfit Sarcoma Study. Retrieved May 3, 2026, from https://4ort.xyz/entity/trabectedin-first-line-therapy-in-unfit-sarcoma-study
MLA “Trabectedin First Line Therapy In Unfit Sarcoma Study.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/trabectedin-first-line-therapy-in-unfit-sarcoma-study.
BibTeX @misc{4ortxyz_trabectedin-first-line-therapy-in-unfit-sarcoma-study_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Trabectedin First Line Therapy In Unfit Sarcoma Study}}, year = {2026}, url = {https://4ort.xyz/entity/trabectedin-first-line-therapy-in-unfit-sarcoma-study}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Trabectedin First Line Therapy In Unfit Sarcoma Study — https://4ort.xyz/entity/trabectedin-first-line-therapy-in-unfit-sarcoma-study (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/trabectedin-first-line-therapy-in-unfit-sarcoma-study · Last refreshed: